Invention Grant
- Patent Title: Compounds which modulate the CB2 receptor
-
Application No.: US12513680Application Date: 2007-11-15
-
Publication No.: US08173638B2Publication Date: 2012-05-08
- Inventor: Angela Berry , Pier Francesco Cirillo , Eugene Richard Hickey , Doris Riether , David Smith Thomson , Lifen Wu
- Applicant: Angela Berry , Pier Francesco Cirillo , Eugene Richard Hickey , Doris Riether , David Smith Thomson , Lifen Wu
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Anthony P. Bottino
- International Application: PCT/US2007/084770 WO 20071115
- International Announcement: WO2008/064054 WO 20080529
- Main IPC: A61P25/00
- IPC: A61P25/00 ; A61K31/55 ; C07D295/13 ; C07D413/12
Abstract:
Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
Public/Granted literature
- US20100009964A1 Compounds Which Modulate The CB2 Receptor Public/Granted day:2010-01-14
Information query
